Description
Transparent adhesive plasters (7.5 x 10 cm) of 2.250 mg (0.1%) betametasone valerate.
Indication
Psoriasis and other skin diseases suitable for treatment with potent corticosteroid molecules.
Status
Approved in Italy, first wave MRP for EU countries concluded (A, F, Gr, Hu, Cz, Sl, UK)
Claims
Effective transdermal delivery without systemic side effects. Clean and practical, avoids the need for occlusive bandages. May be cut according to the dimensions and shape of the lesions avoiding excessive absorption of the product and atrophy of the healthy skin
Countries available for licensing
A wide range of markets (EU, USA, South America, Middle and Far East) are still available on exclusive or semi-exclusive basis. Possibilities for a global agreement.
For details see Page Extensions
For information please contact:
